We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $15.1B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
+16%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
AUM
$15.1B
AUM Growth
+$11.5B
Cap. Flow
+$10.9B
Cap. Flow %
71.99%
Top 10 Hldgs %
18.25%
Holding
5,282
New
1,517
Increased
3,296
Reduced
222
Closed
78

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.68%
2 Technology 13.1%
3 Industrials 6.81%
4 Financials 6.59%
5 Energy 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REM icon
5151
iShares Mortgage Real Estate ETF
REM
$537M
$67 ﹤0.01%
3
+1
+50% +$22
PPHC
5152
Public Policy Holding Co
PPHC
$331M
$66 ﹤0.01%
+9
New +$106
ACHV icon
5153
Achieve Life Sciences
ACHV
$834M
$65 ﹤0.01%
10
+9
+900% +$43
PPI
5154
AXS Astoria Inflation Sensitive ETF
PPI
$162M
$64 ﹤0.01%
+3
New +$65
MTEX icon
5155
Mannatech
MTEX
$13M
$63 ﹤0.01%
12
QUIK icon
5156
QuickLogic
QUIK
$198M
$60 ﹤0.01%
3
SPCE icon
5157
Virgin Galactic
SPCE
$446M
$59 ﹤0.01%
20
+18
+900% +$59
BW icon
5158
Babcock & Wilcox
BW
$1.07B
$56 ﹤0.01%
+4
New +$68
DMAC icon
5159
DiaMedica Therapeutics
DMAC
$345M
$56 ﹤0.01%
+8
New +$49
CMBT
5160
CMB.TECH NV
CMBT
$5.32B
$56 ﹤0.01%
4
-30
-88% -$432
CRVO icon
5161
CervoMed
CRVO
$39.3M
$53 ﹤0.01%
17
+3
+21% +$11
DBA icon
5162
Invesco DB Agriculture Fund
DBA
$1.26B
$53 ﹤0.01%
+2
New +$55
CTXR icon
5163
Citius Pharmaceuticals
CTXR
$16.5M
$51 ﹤0.01%
+84
New +$57
BNKK
5164
Bonk Inc
BNKK
$10.4M
$51 ﹤0.01%
33
-26
-44% -$56
MRAM icon
5165
Everspin Technologies
MRAM
$403M
$48 ﹤0.01%
2
-20
-91% -$448
PYXS icon
5166
Pyxis Oncology
PYXS
$269M
$42 ﹤0.01%
14
+13
+1,300% +$25
SAFX
5167
XCF Global Inc
SAFX
$148M
$42 ﹤0.01%
95
+68
+252% +$31
KSCP icon
5168
Knightscope
KSCP
$33.3M
$38 ﹤0.01%
+18
New +$51
SMTK
5169
SmartKem
SMTK
$1.94M
$36 ﹤0.01%
+3
New +$45
CABA icon
5170
Cabaletta Bio
CABA
$529M
$31 ﹤0.01%
10
+8
+400% +$26
GENVR
5171
Gen Digital Inc Contingent Value Rights
GENVR
$31 ﹤0.01%
24
+19
+380% +$20
AIRE icon
5172
reAlpha
AIRE
$9.67M
$28 ﹤0.01%
+14
New +$51
CRBP icon
5173
Corbus Pharmaceuticals
CRBP
$211M
$28 ﹤0.01%
3
TMQ
5174
Trilogy Metals
TMQ
$625M
$28 ﹤0.01%
+8
New +$33
DFDVW
5175
DeFi Development Corp Warrant
DFDVW
$2.89M
$28 ﹤0.01%
+102
New +$50

Similar funds

Arax Advisory Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Arax Advisory Partners held 5,282 positions worth $15.1B, up 326% from $3.54B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Arax Advisory Partners deployed $10.9B of net new capital in Q2 2026, opening 1,517 new positions and adding to 3,296 existing holdings. Its largest new stake was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 70% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares High Yield Muni Active ETF, an estimated $4.53M trimmed.

  • Arax Advisory Partners's largest Q2 2026 buy was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.
  • Arax Advisory Partners added most to Apple in Q2 2026, an estimated $331M increase.
  • Arax Advisory Partners's biggest Q2 2026 reduction was iShares High Yield Muni Active ETF, cutting an estimated $4.53M.
  • Arax Advisory Partners fully exited Monroe Capital Corp in Q2 2026, selling an estimated $379K.
  • Arax Advisory Partners's ten largest holdings make up 18% of its $15.1B portfolio in Q2 2026.
  • Arax Advisory Partners opened 1,517 new positions and closed 78 in Q2 2026.
  • Arax Advisory Partners's portfolio value rose 326% quarter-over-quarter to $15.1B.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.